glp-1 agonists and sglt2 inhibitors Comparative effectiveness of inhibitors, receptor agonists, DPP-4 inhibitors, sulfonylureas on risk of major adverse cardiovascular events: emulation of a randomised target trial using electronic health records If your skin hurts -Primary Health Interest: Heart Frequency:1 month supply

glp-1 agonists and sglt2 inhibitors Comparative effectiveness of inhibitors, receptor agonists, DPP-4 inhibitors, sulfonylureas on risk of major adverse cardiovascular events: emulation of a randomised target trial using electronic health records If your skin hurts -Primary Health Interest: Heart Frequency:1 month supply

If your skin hurts to touch while on GLP-1, you're not imagining it. A new case series documents allodynia as a dose-dependent side effect of GLP-1 medications. Here's what we know so

December 6, 2023

-Primary Health Interest: Heart

Frequency:1 month supply

Available online: 16.Buckley S.T., Bækdal T.A., Vegge A., Maarbjerg S.J., Pyke C., Ahnfelt-Rønne J., Madsen K.G., Schéele S.G., Alanentalo T., Kirk R.K., et al